SPL026
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SPL026, covering 2024-03-27 to 2024-06-14. Get the full timeline:
Most recent: Clinical Trial Update: SPL026 With or Without SSRIs in Participants With MDD [Phase 1]